Diabetes and Endocrine Trials

Diabetes

• (112-24) A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity (TRIUMPH-5)
• (144-23) A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control
• (162-21) A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Diamyd® to Preserve Endogenous Beta Cell Function in Adolescents and Adults With Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 Haplotype
• (183-23) In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2 – Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
• (244-21) Open, Single Arm, Prospective, Multicenter Study of an Investigational Extended Wear Insulin Infusion Set During Home Use in People With Type 1 Diabetes

Endocrine

• (231-23) A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism

Your participation in any trial is entirely voluntary. You may decide to withdraw at any time without losing the benefits of your standard medical care. 

To learn more about available clinical trials, please contact us at 949-764-4577 or clinicalresearch@hoag.org.